Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A morphologic variant of extrahepatic bile duct adenocarcinoma characterized by the presence of malignant glandular epithelium composed of clear cells.
Biomarker and diagnostic research for extrahepatic bile duct clear cell adenocarcinoma has been reported in the published literature.
No clinical trials have been registered for extrahepatic bile duct clear cell adenocarcinoma.
8 publications have been identified in PubMed for extrahepatic bile duct clear cell adenocarcinoma. Research spans Case Report / Case Series (50%), Diagnostic / Biomarker (25%), and Basic Science / Preclinical (13%).
Dai G (2025). [PMID: 40909959](https://pubmed.ncbi.nlm.nih.gov/40909959/). *Frontiers in oncology*. [Basic Science / Preclinical]
Jalil SA (2025). [PMID: 40620746](https://pubmed.ncbi.nlm.nih.gov/40620746/). *Case reports in gastrointestinal medicine*. [Case Report / Case Series]
Ishteyaque S (2025). [PMID: 40632359](https://pubmed.ncbi.nlm.nih.gov/40632359/). *Journal of molecular histology*. [Case Report / Case Series]
Bilgi Kirmaci M (2025). [PMID: 40809428](https://pubmed.ncbi.nlm.nih.gov/40809428/). *Front Med (Lausanne)*. [Case Report / Case Series]
Shibata Y (2024). [PMID: 38693425](https://pubmed.ncbi.nlm.nih.gov/38693425/). *Clinical journal of gastroenterology*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 2:33 PM UTC
Wang Y (2024). [PMID: 38491381](https://pubmed.ncbi.nlm.nih.gov/38491381/). *Molecular cancer*. [Gene Therapy / Novel Therapeutics]
Salem A (2024). [PMID: 38894777](https://pubmed.ncbi.nlm.nih.gov/38894777/). *Cureus*. [Diagnostic / Biomarker]
Gerber TS (2024). [PMID: 38212892](https://pubmed.ncbi.nlm.nih.gov/38212892/). *International journal of cancer*. [Diagnostic / Biomarker]